Letrozole Tablets
LETORIT-2.5 contains Letrozole IP 2.5 mg formulated for use in approved hormonal therapy indications under medical supervision.
Letrozole 2.5 mg Tablets
LETORIT-2.5 is a Letrozole IP 2.5 mg formulation, packed as 10X10 ALU-ALU. Indicated for breast cancer,gyne, to be used on the advice of a registered medical practitioner. Manufactured at our own WHO-GMP certified unit at Derabassi, Punjab. Supplied for third party manufacturing, private label and PCD franchise across India.
Letrozole Tablets
LETORIT-2.5 is a Letrozole IP 2.5 mg formulation, packed as 10X10 ALU-ALU. Indicated for breast cancer,gyne, to be used on the advice of a registered medical practitioner. Manufactured at our own WHO-GMP certified unit at Derabassi, Punjab. Supplied for third party manufacturing, private label and PCD franchise across India.
Manufactured under WHO-GMP certified facilities with rigorous quality testing and safety protocols.